Trials / Conditions / Local Advanced or Metastatic NSCLC
Local Advanced or Metastatic NSCLC
3 registered clinical trials studyying Local Advanced or Metastatic NSCLC — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC NCT07294261 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or M NCT06380348 | Shanghai JMT-Bio Inc. | Phase 3 |
| Active Not Recruiting | JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized NCT06391944 | Shanghai JMT-Bio Inc. | Phase 2 |